should i switch to tirzepatide from semaglutide vs. Semaglutide: What You Know Why You Might Tolerate One

October 16, 2025 The New Jersey Supreme Court approved consolidating gastroparesis and vision-loss lawsuits in two separate multicounty litigations (MCLs) in state court for faster handling

Autonomic Neuropathy is Associated with the Lack of Glucagon-like Peptide-1 Receptor Agonists Treatment Efficacy in Patients with Type 2 Diabetes

Dosing and Administration Typical Dose : 1.25 mg to 2 mg (0.250.4 mL) per dose Administration : Intranasal spray in one or both nostrils , as directed Timing : Use 1530 minutes before anticipated sexual activity Frequency : No more than 1 dose per 24-hour period

Care review: Ask what evaluation is needed